Deep Track Capital’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-531,857
| Closed | -$7.44M | – | 80 |
|
2024
Q3 | $7.44M | Sell |
531,857
-6,838,143
| -93% | -$95.7M | 0.24% | 59 |
|
2024
Q2 | $60.6M | Hold |
7,370,000
| – | – | 1.81% | 21 |
|
2024
Q1 | $56.8M | Hold |
7,370,000
| – | – | 1.63% | 26 |
|
2023
Q4 | $66.3M | Hold |
7,370,000
| – | – | 2.21% | 14 |
|
2023
Q3 | $65.9M | Hold |
7,370,000
| – | – | 2.54% | 14 |
|
2023
Q2 | $113M | Buy |
7,370,000
+1,222,732
| +20% | +$18.8M | 5.24% | 4 |
|
2023
Q1 | $138M | Buy |
6,147,268
+1,565,268
| +34% | +$35.2M | 5.68% | 3 |
|
2022
Q4 | $96.4M | Buy |
4,582,000
+582,000
| +15% | +$12.2M | 4.05% | 4 |
|
2022
Q3 | $98.6M | Buy |
4,000,000
+419,300
| +12% | +$10.3M | 4.51% | 3 |
|
2022
Q2 | $86.8M | Buy |
3,580,700
+446,197
| +14% | +$10.8M | 5.7% | 3 |
|
2022
Q1 | $80.8M | Buy |
3,134,503
+684,503
| +28% | +$17.6M | 5.18% | 3 |
|
2021
Q4 | $76M | Buy |
+2,450,000
| New | +$76M | 5.37% | 2 |
|